Journal
RESPIROLOGY CASE REPORTS
Volume 9, Issue 5, Pages -Publisher
WILEY
DOI: 10.1002/rcr2.744
Keywords
Acute respiratory distress syndrome; coronavirus disease 2019; nintedanib; pulmonary fibrosis; severe acute respiratory syndrome coronavirus 2
Categories
Ask authors/readers for more resources
A 78-year-old Japanese woman without a smoking history suffered from severe COVID-19, requiring mechanical ventilation and developing pulmonary fibrosis. She was gradually able to improve her respiratory function with methylprednisolone and nintedanib treatment, but still needed oxygen therapy.
A 78-year-old Japanese woman with no smoking history suffered from near-fatal coronavirus disease 2019 (COVID-19) requiring four-week invasive mechanical ventilation, with subsequent radiological features of pulmonary fibrosis. Although methylprednisolone gradually improved her respiratory condition, her oxygenation and exercise tolerance had drastically deteriorated, necessitating high-flow nasal cannula oxygen therapy. In parallel with tapering systemic steroid, the patient was treated with nintedanib. Three months later, the patient was able to walk with a walking aid using oxygen at 4 L/min. The present case is an indication that nintedanib might provide a novel therapeutic approach for managing post-COVID-19 fibrosis, although further studies are warranted.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available